Intuitive Surgical - ISRG Stock Forecast, Price & News

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $237.85 on Thursday. The firm's 50 day moving average price is $212.85 and its 200-day moving average price is $248.92. Intuitive Surgical has a 52-week low of $186.83 and a 52-week high of $369.69. The company has a market cap of $84.94 billion, a PE ratio of 60.52, a P/E/G ratio of 6.70 and a beta of 1.29.

Intuitive Surgical (NASDAQ:ISRG - Get Rating) last released its quarterly earnings data on Thursday, July 21st. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.01 by $0.13. Intuitive Surgical had a net margin of 24.05% and a return on equity of 12.04%. During the same quarter in the prior year, the firm earned $1.42 EPS. On average, analysts forecast that Intuitive Surgical will post 3.76 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several recent research reports. Wells Fargo & Company decreased their target price on shares of Intuitive Surgical to $265.00 in a research report on Friday, July 22nd. TheStreet lowered shares of Intuitive Surgical from a "b-" rating to a "c+" rating in a research report on Thursday, May 19th. Citigroup reduced their price objective on shares of Intuitive Surgical from $360.00 to $305.00 in a research report on Tuesday, May 17th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Intuitive Surgical from $225.00 to $205.00 in a research report on Friday, July 22nd. Finally, The Goldman Sachs Group reduced their price objective on shares of Intuitive Surgical from $319.00 to $273.00 and set a "buy" rating on the stock in a research report on Friday, July 29th. Seven research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $273.23.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CEO Gary S. Guthart sold 79,412 shares of the firm's stock in a transaction that occurred on Tuesday, July 26th. The shares were sold at an average price of $216.30, for a total value of $17,176,815.60. Following the completion of the sale, the chief executive officer now directly owns 54,607 shares in the company, valued at $11,811,494.10. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Intuitive Surgical news, Director Amal M. Johnson sold 6,375 shares of the firm's stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $238.04, for a total value of $1,517,505.00. Following the completion of the transaction, the director now owns 11,224 shares of the company's stock, valued at $2,671,760.96. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Gary S. Guthart sold 79,412 shares of the firm's stock in a transaction on Tuesday, July 26th. The stock was sold at an average price of $216.30, for a total transaction of $17,176,815.60. Following the completion of the transaction, the chief executive officer now directly owns 54,607 shares of the company's stock, valued at approximately $11,811,494.10. The disclosure for this sale can be found here. Insiders sold a total of 94,787 shares of company stock worth $20,719,321 over the last three months. Corporate insiders own 0.90% of the company's stock.